Tag: Crohn’s Disease
CDC: Hospitalization Rates Stabilizing for Crohn’s Disease
Improvement from 1998 to 2004 which saw more than 4 percent increases in hospitalizations each year
Visceral Fat Differentiates Crohn’s From Intestinal Tuberculosis
High sensitivity, specificity for differentiation with cut-off of 0.63 for visceral fat/subcutaneous fat ratio
Case Report: Ustekinumab for Crohn’s Continued in Pregnancy
Patient receiving UST maintenance therapy had uneventful pregnancy, delivered healthy baby
Fecal Calprotectin Levels ID Severity of Crohn’s in Small Bowel
FC correlates with endoscopic index for CD score, and with computed tomography enterography score
Ustekinumab Shows Promise in Crohn’s Disease
Medication potentially helpful in those for whom other treatments haven't worked
Two Genetic Subtypes of Crohn’s Disease Identified
Findings may help explain why the disease is so tough to treat, researchers say
2 mg/kg/day Azathioprine Best for Crohn’s in Chinese Patients
Significantly higher complete remission rate and response rate with 2 mg/kg/day than 1 mg/kg/day
Smokers More Prone to Relapse After Crohn’s Surgery
Research supports mercaptopurine for smokers, but not for nonsmokers
Oral Contraceptive Use Ups Surgery Risk in Crohn’s
Long-term use of oral contraceptives, especially combination type, linked to increased surgery risk
Review Links Tonsillectomy to Risk of Crohn’s Disease
No correlation seen for tonsillectomy and risk of development of ulcerative colitis
